Teladoc Health, Inc. — Form 8-K

Michael Grasher appointed Chief Financial Officer of Teladoc Health, effective August 31, 2026. Grasher receives $550,000 base salary, $500,000 signing bonus (subject to clawback if resignation without Good Reason within 12 months), and $3,000,000 inducement equity grant ($1.5M RSUs over 3 years + $1.5M PSUs). He is eligible for 85% target annual bonus (max 200%) and severance of 12 months base salary plus pro-rata bonus upon qualifying termination; 18 months base salary plus full target bonus upon qualifying termination within 12 months of a Change of Control. Non-compete and non-solicitation covenants apply for 12 months post-termination across North America, South America, Europe, and Australia.